H-Phe-Pro-Arg-OH |
| Catalog No.GA22811 |
FPR is a tripeptide analog of the thrombin-receptor-derived peptide SFLLR (H-1408). In the chick chorioallantoic membrane system it inhibited angiogenesis and caused a complete reversal of the angiogenesis-promoting effect of the thrombin-receptor-activating tetradecapeptide (TRAP (1-14), H-8105). FPR has potential applications in the nonthrombotic actions of thrombin, e.g. cancer and inflammation, where angiogenesis is thought to play a pivotal role.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 37553-80-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
FPR is a tripeptide analog of the thrombin-receptor-derived peptide SFLLR. In the chick chorioallantoic membrane system it inhibited angiogenesis and caused a complete reversal of the angiogenesis-promoting effect of the thrombin-receptor-activating te
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *